Wednesday, 5 October 2011

Merck, Ono developing oral multiple sclerosis drug



Source SFGate:
Merck KGaA said its Merck Serono unit will develop and market a pill for multiple sclerosis with Japan's Ono Pharmaceutical Co. to compete with a similar product made by Novartis AG.  For more click here.